RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Harbin Pharmaceutical Group Co Stock

Harbin Pharmaceutical Group Co Liabilities 2024

Harbin Pharmaceutical Group Co Liabilities

9.39 B CNY

Ticker

600664.SS

ISIN

CNE0000009T3

In 2024, Harbin Pharmaceutical Group Co's total liabilities amounted to 9.39 B CNY, a 3.11% difference from the 9.1 B CNY total liabilities in the previous year.

Harbin Pharmaceutical Group Co Aktienanalyse

What does Harbin Pharmaceutical Group Co do?

Harbin Pharmaceutical Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Harbin Pharmaceutical Group Co's Liabilities

Harbin Pharmaceutical Group Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Harbin Pharmaceutical Group Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Harbin Pharmaceutical Group Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Harbin Pharmaceutical Group Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Harbin Pharmaceutical Group Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Harbin Pharmaceutical Group Co stock

What is the level of liabilities of Harbin Pharmaceutical Group Co this year?

Harbin Pharmaceutical Group Co has a debt balance of 9.39 B CNY this year.

What were the liabilities of Harbin Pharmaceutical Group Co compared to the previous year?

The liabilities of Harbin Pharmaceutical Group Co have increased by 3.11% increased compared to the previous year.

What are the consequences of high debt for investors of Harbin Pharmaceutical Group Co?

High liabilities can pose a risk for investors of Harbin Pharmaceutical Group Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Harbin Pharmaceutical Group Co?

Low liabilities mean that Harbin Pharmaceutical Group Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Harbin Pharmaceutical Group Co affect the company?

An increase in liabilities of Harbin Pharmaceutical Group Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Harbin Pharmaceutical Group Co affect the company?

A decrease in the liabilities of Harbin Pharmaceutical Group Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Harbin Pharmaceutical Group Co?

Some factors that can influence the liabilities of Harbin Pharmaceutical Group Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Harbin Pharmaceutical Group Co so important for investors?

The liabilities of Harbin Pharmaceutical Group Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Harbin Pharmaceutical Group Co take to modify the liabilities?

To change its liabilities, Harbin Pharmaceutical Group Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Harbin Pharmaceutical Group Co pay?

Over the past 12 months, Harbin Pharmaceutical Group Co paid a dividend of 0.5 CNY . This corresponds to a dividend yield of about 15.34 %. For the coming 12 months, Harbin Pharmaceutical Group Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Harbin Pharmaceutical Group Co?

The current dividend yield of Harbin Pharmaceutical Group Co is 15.34 %.

When does Harbin Pharmaceutical Group Co pay dividends?

Harbin Pharmaceutical Group Co pays a quarterly dividend. This is distributed in the months of September, December, May, June.

How secure is the dividend of Harbin Pharmaceutical Group Co?

Harbin Pharmaceutical Group Co paid dividends every year for the past 3 years.

What is the dividend of Harbin Pharmaceutical Group Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Harbin Pharmaceutical Group Co located?

Harbin Pharmaceutical Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Harbin Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Harbin Pharmaceutical Group Co from 5/4/2018 amounting to 0.5 CNY, you needed to have the stock in your portfolio before the ex-date on 5/4/2018.

When did Harbin Pharmaceutical Group Co pay the last dividend?

The last dividend was paid out on 5/4/2018.

What was the dividend of Harbin Pharmaceutical Group Co in the year 2023?

In the year 2023, Harbin Pharmaceutical Group Co distributed 0 CNY as dividends.

In which currency does Harbin Pharmaceutical Group Co pay out the dividend?

The dividends of Harbin Pharmaceutical Group Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Harbin Pharmaceutical Group Co

Our stock analysis for Harbin Pharmaceutical Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Harbin Pharmaceutical Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.